Industry Updates
Press Releases
Cega creates new role to meet rising demand for private repatriation
CEGA, the repatriation, medical assistance and claims provider, has appointed a new business development manager to meet the rising demand for private medical repatriations from travellers.
Nick Simon, who takes on the new role, will focus on the needs of...
Press Releases
ACG keen to Improve Technology for Authentication and Traceability of Capsules for the Pharmaceutical and Nutraceutical Industry: Signs Letter of Intent with Applied DNA...
Molecular labeling of capsules is intended to prevent counterfeiting The Letter of Intent between Applied DNA Sciences, Inc. and ACG grants ACG the rights to use the established SigNature® molecular marking and authentication technologies of Applied DNA.
This allows the...
Press Releases
An additional FDA approval for Lilly’s Verzenio™ (abemaciclib), initial treatment for advanced breast cancer
Eli Lilly and Company announced that the U.S. FDA has approved VerzenioTM (abemaciclib) in combination with an aromatase inhibitor (AI) as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor...
Press Releases
Avera Health achieves significant cost savings and improved patient outcomes in rural areas with Philips eICU program
Ahead of the 2018 Annual Healthcare Information and Management Systems Society (HIMSS) Conference, Royal Philips , a global leader in health technology, today announced the Philips eICU program has helped Avera Health, a South Dakota-based integrated health system, enhance...
Press Releases
UHG to maintain Bundled payments with Health Care Providers in Fee-for-Service Medicare
UnitedHealth Group announced advancements in the company’s collaboration with individual doctors, health systems and government as the use of bundled payment models expands in traditional fee-for-service Medicare.
UnitedHealth Group (NYSE: UNH) today announced advancements in the company’s collaboration with individual...
Press Releases
Terumo BCT collaboration with stafaCT will enhance patient pathways for cellular treatments
Terumo BCT announced that it will be the exclusive distributor for Stafa Cellular Therapy (StafaCT), a U.S.-based software developer.
StafaCT software supports healthcare facilities and cell labs as they manage each phase of the cellular therapy process including patient referral,...
Press Releases
Kazie receives FDA approval for its GDC- 0084
Kazia Therapeutics Limited , an Australian biotechnology company dedicated to the field of oncology, is pleased to announce that the FDA of the United States has granted the orphan drug designation (ODD) to GDC-0084, a new product under clinical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.